Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 28Glioma 20Brain Neoplasms 18Astrocytoma 13Neuroblastoma 12Lung Neoplasms 11Breast Neoplasms 10Medulloblastoma 9Central Nervous System Neoplasms 9Osteosarcoma 7Carcinoma, Non-Small-Cell Lung 7Wilms Tumor 6Lymphoma, Non-Hodgkin 6Hepatoblastoma 6Ependymoma 6Rhabdoid Tumor 5Neuroectodermal Tumors, Primitive, Peripheral 5Meningioma 5Meningeal Carcinomatosis 5Melanoma 5Histiocytosis, Langerhans-Cell 5Gliosarcoma 5Sarcoma 4Rhabdomyosarcoma 4Prostatic Neoplasms 4Pheochromocytoma 4Paraganglioma 4Neoplasm Metastasis 4Ganglioneuroblastoma 4Thyroid Neoplasms 3

Interventions

Specimen Handling 1Mental Status and Dementia Tests 1Memantine 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Carcinoma × Specimen Handling × CNS × Clear all
NCT04939597 2025-12-22

A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

Children's Oncology Group

Phase 3 Active not recruiting
192 enrolled
CNS

Central Nervous System Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡